CONSOLACIÓN
MELGUIZO ALONSO
CATEDRÁTICA DE UNIVERSIDAD
OCTAVIO
CABA PÉREZ
PROFESOR TITULAR DE UNIVERSIDAD
Publicaciones en las que colabora con OCTAVIO CABA PÉREZ (30)
2023
-
Serum nuclear magnetic resonance metabolomics analysis of human metastatic colorectal cancer: Biomarkers and pathway analysis
NMR in Biomedicine, Vol. 36, Núm. 9
2021
-
Circulating ptgs2, jag1, gucy2c and pgf mrna in peripheral blood and serum as potential biomarkers for patients with metastatic colon cancer
Journal of Clinical Medicine, Vol. 10, Núm. 11
2020
-
Discovery of pancreatic adenocarcinoma biomarkers by untargeted metabolomics
Cancers, Vol. 12, Núm. 4
-
MMR-proficient and MMR-deficient colorectal cancer cells: 5-Fluorouracil treatment response and correlation to CD133 and MGMT expression
Journal of Biosciences, Vol. 45, Núm. 1
2019
-
Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer
Scientific Reports, Vol. 9, Núm. 1
2018
-
Proteomic biomarkers in body fluids associated with pancreatic cancer
Oncotarget, Vol. 9, Núm. 23, pp. 16573-16587
2017
-
Untargeted LC-HRMS-based metabolomics for searching new biomarkers of pancreatic ductal adenocarcinoma: A pilot study
SLAS Discovery, Vol. 22, Núm. 4, pp. 348-359
2016
-
Current status of immunotherapy treatments for pancreatic cancer
Journal of Clinical Gastroenterology, Vol. 50, Núm. 10, pp. 836-848
2015
-
Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(Butylcyanoacrylate) nanoparticles
Drug Design, Development and Therapy, Vol. 9, pp. 6433-6444
-
Temozolomide resistance in glioblastoma cell lines: Implication of MGMT, MMR, P-glycoprotein and CD133 expression
PLoS ONE, Vol. 10, Núm. 10
-
Tissue Specific Promoters in Colorectal Cancer
Disease Markers, Vol. 2015
2014
-
Transcriptional Profiling of Peripheral Blood in Pancreatic Adenocarcinoma Patients Identifies Diagnostic Biomarkers
Digestive Diseases and Sciences, Vol. 59, Núm. 11, pp. 2714-2720
2013
-
Modulation of multidrug resistance gene expression in peripheral blood mononuclear cells of lung cancer patients and evaluation of their clinical significance
Cancer Chemotherapy and Pharmacology, Vol. 71, Núm. 2, pp. 537-541
2012
-
5-fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer
International Journal of Nanomedicine, Vol. 7, pp. 95-107
-
Gef gene therapy enhances the therapeutic efficacy of cytotoxics in colon cancer cells
Biomedicine and Pharmacotherapy, Vol. 66, Núm. 7, pp. 563-567
-
How is gene transfection able to improve current chemotherapy? The role of combined therapy in cancer treatment
Current Medicinal Chemistry, Vol. 19, Núm. 12, pp. 1870-1888
-
Modulation of MDR1 and MRP3 gene expression in lung cancer cells after paclitaxel and carboplatin exposure
International Journal of Molecular Sciences, Vol. 13, Núm. 12, pp. 16624-16635
-
New gene therapy strategies for cancer treatment: A review of recent patents
Recent Patents on Anti-Cancer Drug Discovery, Vol. 7, Núm. 3, pp. 297-312
2011
-
Development of patents and clinical trials on regenerative therapy: Gene therapy
Recent Patents on Regenerative Medicine, Vol. 1, Núm. 2, pp. 182-194
2010
-
Differentiation of intestinal epithelial cells mediated by cell confluence and/or exogenous nucleoside supplementation
Cells Tissues Organs, Vol. 191, Núm. 6, pp. 478-488